SCHEMBL13267165

SCHEMBL13267165

CSC[C@H](NS(=O)(=O)c1ccc(-c2ccc(CN3CCOCC3)cc2)cc1)C(=O)NO

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADAMTS4 O75173 1/20 0.54
▸ MMP2 P08253 5/20 0.53
▸ MMP13 P45452 3/20 0.53
▸ MMP1 P03956 3/20 0.53
▸ MMP3 P08254 2/20 0.53
▸ MMP9 P14780 2/20 0.48
▸ HRH3 Q9Y5N1 1/20 0.46
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ AIMP2 Q13155 1/20 0.45
▸ MMP14 P50281 1/20 0.44
▸ ADAM17 P78536 1/20 0.44
▸ LMNA P02545 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ GALR3 O60755 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13244942 0.91 MMP2 (0.51) ADAMTS4MMP2MMP13MMP3
SCHEMBL13266866 0.85 MMP2 (0.71) ADAMTS4MMP2MMP13MMP1MMP3
SCHEMBL13984815 0.85 MMP2 (0.71) ADAMTS4MMP2MMP13MMP1MMP3
SCHEMBL13267164 0.83 ADAMTS4 (0.62) ADAMTS4MMP2MMP13MMP1MMP3
SCHEMBL13267482 0.81 ADAMTS4 (0.56) ADAMTS4MMP2MMP13MMP1MMP3
SCHEMBL13244755 0.77 MMP2 (0.58) ADAMTS4MMP2MMP13MMP3MMP9
SCHEMBL3016012 0.77 MMP2 (0.58) ADAMTS4MMP2MMP13MMP3MMP9
SCHEMBL3016017 0.77 MMP2 (0.58) ADAMTS4MMP2MMP13MMP3MMP9
SCHEMBL13244664 0.74 ADAMTS4 (0.55) ADAMTS4MMP13MMP1MMP9MMP14
SCHEMBL13266867 0.74 MMP1 (0.61) ADAMTS4MMP2MMP13MMP1MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100190766-A1 ANTIBACTERIAL AGENTS ACHAOGEN, INC. (US) 2010-07-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190766-A1 ANTIBACTERIAL AGENTS MRPL21, SI, ABCB11 ADAMTS4 3184/4885MMP2 446/4885MMP13 2049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback